Publicaciones en colaboración con investigadores/as de Princess Margaret Hospital (4)

2020

  1. Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study

    Blood Cancer Journal, Vol. 10, Núm. 9

2016

  1. International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

    Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557

2009

  1. A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older

    Blood, Vol. 114, Núm. 6, pp. 1166-1173

2004

  1. Genetics and Cytogenetics of Multiple Myeloma: A Workshop Report

    Cancer Research